As of 30 Sep 2025, 7 institutional investors reported holding $4,500,000 in principal (par value) of EVOLENT HEALTH INC - NOTE 1.500%10/1.
| Period | Principal | Value | Change | Price (% of par) (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q3 | $4,500,000 | $4,463,668 | -$129,827,599 | 99.31% | 7 |
| 2025 Q2 | $173,633,000 | $171,973,796 | +$111,888 | 98.52% | 10 |
| 2025 Q1 | $173,682,000 | $170,808,890 | +$1,915,069 | 97.73% | 9 |
| 2024 Q4 | $171,719,000 | $167,318,058 | -$12,154,621 | 96.88% | 9 |
| 2024 Q3 | $182,962,000 | $193,561,523 | -$526,404 | 105.04% | 14 |
| 2024 Q2 | $181,685,500 | $181,195,280 | +$981,638 | 96.88% | 14 |
| 2024 Q1 | $180,676,500 | $209,850,274 | +$12,960,703 | 114.29% | 10 |
| 2023 Q4 | $169,263,851 | $209,521,181 | +$7,450,871 | 114.33% | 12 |
| 2023 Q3 | $160,940,063 | $183,991,019 | +$3,303,252 | 106.81% | 13 |
| 2023 Q2 | $162,822,732 | $198,542,058 | +$47,109,042 | 114.14% | 18 |
| 2023 Q1 | $120,898,674 | $156,834,918 | -$10,826,032,338 | 118.96% | 15 |
| 2022 Q4 | $177,137,800 | $193,838,456 | +$11,386,720 | 108.14% | 24 |
| 2022 Q3 | $145,463,061 | $181,482,016 | -$8,917,618 | 125.8% | 21 |
| 2022 Q2 | $164,293,261 | $175,525,063 | -$449,813,876 | 113.34% | 22 |
| 2022 Q1 | $168,943,061 | $203,539,889 | +$4,787,238 | 118.31% | 22 |
| 2021 Q4 | $158,514,761 | $183,014,942 | -$3,463,867 | 109.63% | 20 |
| 2021 Q3 | $161,964,761 | $200,262,160 | +$8,769,972 | 114.71% | 22 |
| 2021 Q2 | $155,692,126 | $164,515,824 | -$8,438,325 | 96.57% | 20 |
| 2021 Q1 | $164,602,126 | $168,993,400 | -$1,422,033,905 | 94.06% | 22 |
| 2020 Q4 | $170,451,000 | $145,748,760 | +$11,136,306 | 85.87% | 19 |
| 2020 Q3 | $160,290,000 | $125,504,400 | +$64,849 | 78.17% | 16 |
| 2020 Q2 | $154,839,000 | $102,722,320 | -$5,804,390 | 63.36% | 18 |
| 2020 Q1 | $164,056,103 | $107,615,048 | +$5,520,850 | 63.2% | 19 |
| 2019 Q4 | $162,900,556 | $117,197,496 | +$111,908,336 | 69.94% | 20 |